Strategic Overview
Piramal Enterprises at a Glance
Financial Services
Key Highlights For The Financial Services Business
Pharma and Healthcare Insights & Analytics
Key Highlights For The Pharma Business
Chairman’s Message
Key Performance Indicators
Performing Stronger Despite Roadblocks
- Stringent USFDA Inspections
- Pricing Pressures in Pharma
- Demonetisation, RERA and GST
- NBFC Liquidity Tightening
Differentiators driving PEL's superior performance
- High Promoter Commitment
- Strong Balance Sheet & Efficient Capital Allocation
- Constantly thinking ahead of the curve
- Proactive measures to mitigate potential risks
- Innovation Culture
- Multiple Drivers of Value Creation
- Trusted Partnerships
Board and Governance
Trusteeship approach
Management Discussion & Analysis
Financial Review
Financial Services
Pharma
Healthcare Insights & Analytics
Risk Management
Human Resources
Information Technology & Digital
Analytics
Environment, Health and Safety
Corporate Social Responsibility
Awards and Recognition
10-Year Financial Highlights
Board & Management Profiles
Board of Directors
Management Team
Statutory Reports
Report on Corporate Governance
Board's Report & Annexures
Business Responsibility Report
Finanacial Statement
Standalone
Independent Auditor's Report
Balance Sheet
Statement of Profit and Loss
Statement of Changes in Equity
Statement of Cash Flows
Notes to Standalone Financial Statements
Form AOC-1
Consolidated
Independent Auditor’s Report
Consolidated Balance Sheet
Consolidated Statement of Profit and Loss
Consolidated Statement of Changes in Equity
Consolidated Statement of Cash Flows
Notes to Consolidated Financial Statements
Download Center
Home
Strategic Overview
Trusteeship Approach
Trusteeship Approach
Delivering to
Our Employees
Know More
Delivering to
Our Customers
Know More
Delivering to
Our Investors
Know More
Delivering to
Our Society
Know More
Previous Page